AI assistant
STAAR SURGICAL CO — Director's Dealing 2021
Mar 15, 2021
31996_dirs_2021-03-15_66ab86d9-f97c-4fae-bf0b-da325da1c25f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-03-12
Reporting Person: Williams Patrick F. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-12 | Common Stock | M | 2513 | $0.00 | Acquired | 33240 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-12 | Common Stock Options | $90.38 | M | 5312 | Acquired | 2031-03-11 | Common Stock (5312) | Direct |
Footnotes
F1: Award of 2513 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/12/22, 1/3 of the RSUs on 3/12/23, and the remaining 1/3 of the RSUs on 3/12/24.
F2: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024.